Protalix BioTherapeutics (PLX) Earnings Date & Reports

Protalix BioTherapeutics Inc is a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx protein expression system or ProCellEx... Show more

Industry: #Servicestothe Health Industry

Get AI intraday signals

A.I. Advisor

published Earnings

PLX is expected to report earnings to fall 320.00% to 10 cents per share on August 18

Protalix BioTherapeutics PLX Stock Earnings Reports

Q2'25

Est.

$0.11

Q1'25

Missed

by $0.08

Q4'24

Est.

$0.10

Q3'24

Missed

by $0.03

Q2'24

Missed

by $0.05

The last earnings report on May 09 showed earnings per share of -5 cents, missing the estimate of 2 cents. With 275.77K shares outstanding, the current market capitalization sits at 112.25M.

View a ticker or compare two or three

Compare

PLX